Compare DLX & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLX | PLSE |
|---|---|---|
| Founded | 1915 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 1994 | 2015 |
| Metric | DLX | PLSE |
|---|---|---|
| Price | $30.75 | $23.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $23.00 | $22.00 |
| AVG Volume (30 Days) | ★ 329.9K | 221.9K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | ★ 52.54 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $2,133,200,000.00 | N/A |
| Revenue This Year | $1.35 | $840.00 |
| Revenue Next Year | $1.30 | $287.54 |
| P/E Ratio | $17.01 | ★ N/A |
| Revenue Growth | ★ 0.54 | N/A |
| 52 Week Low | $13.61 | $12.56 |
| 52 Week High | $30.77 | $26.30 |
| Indicator | DLX | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 72.73 | 62.61 |
| Support Level | $25.46 | $13.62 |
| Resistance Level | N/A | $26.30 |
| Average True Range (ATR) | 0.76 | 1.55 |
| MACD | 0.26 | 0.23 |
| Stochastic Oscillator | 93.71 | 97.26 |
Deluxe Corp is principally a payments and data company. Its reportable segments are: Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment, which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services, as well as financial institution profitability reporting and business incorporation services.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.